ICBT for Antenatal Depression

Antenatal Depression Clinical Trial

Official title:

Psychological Treatment Via the Internet for Antenatal Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02366429
• Other study ID #: 20141959311
• Status: Completed
• Phase: N/A
• First received: February 12, 2015
• Last updated: September 2, 2016
• Start date: February 2015
• Est. completion date: March 2016

Study information

• Verified date: September 2016
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Health authority: Sweden: Regional Ethical Review Board
• Study type: Interventional

Clinical Trial Summary

Randomized controlled trial evaluating an Internet-delivered Cognitive Behavioral Therapy (ICBT) adapted for pregnant women suffering from antenatal depression. The ICBT-program will be added to treatment as usual (TAU) and compared to TAU only.

Participants (n=60) are recruited from all over Sweden (only Swedish citizens can participate) and are assessed and treated on a distance via a secure web platform and telephone.

Description:

In order to evaluate feasibility and effectiveness of an ICBT-program for antenatal depression that will be used in a larger clinical trial, the current RCT (n=60) will be performed and act as a pilot for the main study.

Participants will all be receiving the regular treatment (TAU) provided at their antenatal clinic and other health care instances. Half of them will be randomized to an add-on of a previously established 10-week long ICBT-program for depression in general, now adapted for pregnant women. The other half will receive TAU during 10 weeks and then freely decide if they want to participate in the pregnancy-adapted ICBT-program (only possible if 10 or more weeks left till estimated delivery date), start the regular ICBT-program for depression within 2-6 weeks post-partum, or decline ICBT-treatment. The participants in this study will be recruited from all over Sweden via internet, advertisements and information at antenatal clinics. A web-based screening questionnaire will form the basis for a first assessment and review of inclusion criteria, followed by a structured telephone interview where diagnoses (SCID-1 for depression, adjusted for DSM 5, and M.I.N.I. for other diagnoses and assessment of suicide risk) and suitability will be assessed, a CGI-rating will be performed, and the final decision on inclusion will be made.

Level of depression pre- and post-treatment will be assessed with MADRS-S filled out via the internet-treatment platform together with the other self-rating measures used in the main study. A questionnaire where the participants evaluate the content of the adapted ICBT-program and their own use and perceived benefit of the treatment methods will also be given at post-treatment and during treatment.

Structured telephone interview will be held at post-treatment, primarily to assess the content of TAU, to administer CGI and a standardized version for MADRS-S (designed to replace missing questionnaire data), and to make a qualitative evaluation of the participants view of the adapted ICBT-program.

The estimated effect of ICBT compared to TAU is 0.8 (Cohen's d) and with 60 participants and some attrition this will result in a statistical power of 80% for this initial, smaller RCT.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: March 2016
• Est. primary completion date: March 2016
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

• pregnant female > 18 years old at gestational week 11-28

• verified moderate depression according to SCID-I with or without concomitant anxiety disorder

• able to understand the Swedish language orally and in written

• able to use the internet for the ICBT

• currently in contact with an antenatal clinic to receive regular care

Exclusion Criteria:

• known drug or alcohol abuse

• serious somatic disorder or psychiatric disorder such as psychosis, bipolar disorder, severe personality disorder, autism or mental retardation and severe melancholic or psychotic depression,

• having started or changed medication with SSRI, SNRI or mood-stabilizers within 3 weeks,

• according to psychiatric assessment have a high suicide risk will be excluded from the study. These women will be helped to receive necessary psychiatric treatment as usual.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Antenatal Depression
• Depression
• Depressive Disorder

Intervention

Behavioral:
• ICBT for antenatal depression
Participants receives active therapist support via the internet to go through a 10-week self-help treatment on a secure web platform

Other:
• TAU
Treatment as usual provided at antenatal clinics and other health care instances

Locations

Country	Name	City	State
Sweden	Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydväst, SLSO	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Self-rated depression measured by Montgomery Asberg Depression Rating Scale	Depression measured by Montgomery Asberg Depression Rating Scale (MADRS-S), a 9-item self-rated measure of change in depression severity. It also screens for suicidality.	Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum	No
Secondary	Self-rated antenatal depression Edinburgh Postnatal Depression Scale	Edinburgh Postnatal Depression Scale (EPDS; Cox, Holden & Sagovsky, 1987)	Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum	No
Secondary	Self-rated function Work and Social Adjustment Scale	Work and Social Adjustment Scale (WSAS; Zahra et al., 2014)	Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum	No
Secondary	Self-rated Insomnia Insomnia Severity Index	Insomnia Severity Index (ISI; Bastien, Vallieres & Morin, 2001)	Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum	No
Secondary	Self-rated function/quality of life Euroqol	Euroqol (EQ-5D ; Hinz et al., 2006),	Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum	No
Secondary	Self-rated anxiety and worry GAD-7	GAD-7(Beard, & Björgvinsson, 2014)	Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum	No
Secondary	Expert rating of overall disease burden Clinical Global Impression - Severity scale	Clinical Global Impression - Severity scale (CGI-S; Guy, 2000)	Change from baseline to post-treatment (after 10 weeks) and to 3-4 weeks post-partum	No

External Links

•   Link